video
Erythromycin CAS 114-07-8

Erythromycin CAS 114-07-8

Erythromycin
CAS 114-07-8
Purity: 99.0%Min | Appearance: Red powder
Molecular Formula: C37H67NO13 | MW: 733.927
Einecs: 204-040-1
Synonyms: erythromycine;erythrocin;erythromycin A

Product Introduction

Dayang Chem (Hangzhou) Co., Ltd. is one of the leading manufacturers and suppliers of erythromycin cas 114-07-8 in China, specialized in providing high quality customized chemicals. Welcome to wholesale bulk erythromycin cas 114-07-8 made in China here and get pricelist from our factory. Good service and reasonable price are available.

 

Product Introduction:

 

1.     Specification

Appearance

Red powder

Assay

99.0% Min

Melting Range

138~140

Loss on Drying

1.0% Max

 

The latest specifications and COA will be sent upon request.

 

2.     Packaging & shipping

Packaging

Bulk Packaging: 10kg ,25kg bag or drum or custom packaging upon request

Transport Classification

Not regulated as a dangerous good

Lead Time

in stock

Shipping Methods

DHL, FedEx, air freight or sea freight

f-Erythromycin

s-Erythromycin

 

3.     Applications

Erythromycin, an oral macrolide antibiotic produced by Streptomyces erythreus, reversibly binds to the 50S ribosome of bacteria, and inhibits protein synthesis.Target: AntibacterialErythromycin is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often prescribed for people who have an allergy to penicillins. For respiratory tract infections, it has better coverage of atypical organisms, including Mycoplasma and legionellosis. It was first marketed by Eli Lilly and Company, and it is today commonly known as EES (erythromycin ethylsuccinate, an ester prodrug that is commonly administered). It is also occasionally used as a prokinetic agent.Erythromycin estolate has been associated with reversible hepatotoxicity in pregnant women in the form of elevated serum glutamic-oxaloacetic transaminase and is not recommended during pregnancy. Some evidence suggests similar hepatotoxicity in other populations. Erythromycin displays bacteriostatic activity or inhibits growth of bacteria, especially at higher concentrations, but the mechanism is not fully understood. By binding to the 50s subunit of the bacterial 70s rRNA complex, protein synthesis and subsequent structure and function processes critical for life or replication are inhibited. Erythromycin interferes with aminoacyl translocation, preventing the transfer of the tRNA bound at the A site of the rRNA complex to the P site of the rRNA complex. Without this translocation, the A site remains occupied and, thus, the addition of an incoming tRNA and its attached amino acid to the nascent polypeptide chain is inhibited. This interferes with the production of functionally useful proteins, which is the basis of this antimicrobial action.

 

4.     Spectrum

t-114-07-8-Erythromycin

 

 

5.     Related Articles

1. Binding properties of antimicrobial agents to lipid membranes using surface plasmon resonance.Biol. Pharm. Bull.   37(8) , 1383-9, (2014)
2. Live-cell and super-resolution imaging reveal that the distribution of wall-associated protein A is correlated with the cell chain integrity of Streptococcus mutans.Mol. Oral Microbiol.   30 , 376-83, (2015)
3. Mechanisms involved in quinolone resistance in Mycoplasma mycoides subsp. capri.Vet. J.   204 , 327-32, (2015)

manufacturer

cerificate

 

 

 

 

Hot Tags: erythromycin cas 114-07-8, China erythromycin cas 114-07-8 manufacturers, suppliers, factory, Naphthoquinone, 106-95-6, 204-781-0, 9 Anthracenemethanol CAS 1468 95 7, C4H5NO2, p-diaminobenzene

Send Inquiry

Home

Phone

E-mail

Inquiry

Bag